From post

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

, , , , , , , , , и . Clin. Vaccine Immunol., 17 (1): 154--159 (января 2010)
DOI: 10.1128/CVI.00384-09

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine, , , , , , , , , и . Clin. Vaccine Immunol., 17 (1): 154--159 (января 2010)Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom, , , , , , и . The Journal of Infectious Diseases, 194 (12): 1745--52 (декабря 2006)PMID: 17109348.Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity, , , , и . Clin. Vaccine Immunol., 17 (5): 840--847 (мая 2010)Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom, , , , , , , , , и . Clin. Vaccine Immunol., 16 (2): 194--199 (февраля 2009)Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles, , , , , , , , , и 3 other автор(ы). Clin. Vaccine Immunol., 16 (8): 1113--1120 (августа 2009)Social behavior and meningococcal carriage in British teenagers, , , , , , , , , и 1 other автор(ы). Emerging Infectious Diseases, 12 (6): 950--7 (июня 2006)PMID: 16707051.Meningococcal C booster not recommended by evidence, , , , и . BMJ (Clinical Research Ed.), (2008)PMID: 18694884.Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals, , , , , , , и . Infection and Immunity, 72 (1): 332--337 (января 2004)PMID: 14688112.No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome, , , , и . Archives of Disease in Childhood, 92 (10): 887--889 (октября 2007)PMID: 17468130.Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experience., , , , , , , , , и 1 other автор(ы). Int. J. Medical Informatics, (2023)